The UFL Group has secured a major contract from one of China’s leading medical organisations, following a successful bid.
The agreement covers the transportation of pharmaceutical reefer containers from various European locations to designated ports across China.
This significant win reinforces UFL Group’s position as a trusted partner in the global cold-chain logistics sector, particularly within the high-value pharmaceutical segment.
The scope of work involves managing complex temperature-controlled shipments, ensuring compliance with stringent international quality and safety standards.
The project is scheduled to commence imminently, with preparations already underway to ensure seamless execution. This achievement underlines UFL Group’s capability to deliver reliable, efficient, and compliant logistics solutions to meet the demands of the international healthcare industry.
U-Freight Group chief executive officer Simon Wong says: “This contract strengthens the U-Freight Group’s role as a trusted global partner, delivering compliant, temperature-controlled pharmaceutical logistics from Europe to China, and reinforcing our commitment to reliability, efficiency and industry-leading quality standards.
“Securing this significant contract with a leading Chinese medical organisation marks an important milestone for the U-Freight Group. It reflects our expertise in managing complex, temperature-controlled pharmaceutical logistics across continents, while maintaining the highest international quality and safety standards.”
